View Older Stories View More Recent Stories

Mar 3, 2020 07:30AM Cytokinetics Announces Preclinical Data for AMG 594 Presented at the Keystone Symposium on Heart Failure
Feb 28, 2020 07:30AM Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
Feb 26, 2020 08:33AM Amgen (AMGN) Cytokinetics (CYTK) and Servier Report Continuation of GALACTIC-HF Following Planned Interim Analysis
Feb 26, 2020 08:30AM Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Feb 26, 2020 08:30AM Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis
Feb 20, 2020 07:30AM Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the Biophysical Society 64th Annual Meeting
Feb 18, 2020 04:00PM Cytokinetics to Announce Fourth Quarter Results on March 3, 2020
Feb 6, 2020 05:57AM Cytokinetics (CYTK) Reports Publication of Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Heart Failure
Feb 6, 2020 04:30AM Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
Feb 6, 2020 04:30AM Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
Jan 22, 2020 07:30AM Cytokinetics Announces Recipients of Second Annual Communications Fellowship Grants
Jan 13, 2020 07:30AM Cytokinetics Announces Vision 2025 and Outlines 2020 Corporate Milestones
Jan 6, 2020 07:30AM Cytokinetics Announces Start of Redwood-HCM, a Phase 2 Clinical Trial of CK-3773274
Dec 18, 2019 07:33AM Cytokinetics (CYTK) Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis
Dec 18, 2019 07:30AM Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis
Dec 5, 2019 07:30AM Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND
Nov 27, 2019 04:00PM Cytokinetics to Participate in the Piper Jaffray Healthcare Conference
Nov 26, 2019 04:00PM Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
Nov 18, 2019 09:06AM Amgen (AMGN), Cytokinetics (CYTK) Announces New Results From COSMIC-HF Presented at AHA
Nov 18, 2019 09:00AM New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function
Nov 18, 2019 09:00AM New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function
Oct 31, 2019 04:00PM Cytokinetics Reports Third Quarter 2019 Financial Results
Oct 24, 2019 04:00PM Cytokinetics to Announce Third Quarter Results on October 31, 2019
Oct 4, 2019 07:31AM Cytokinetics (CYTK) Announces Presentation of Additional Analyses From FORTITUDE-ALS at NEALS
Oct 4, 2019 07:30AM Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting
Sep 26, 2019 04:00PM Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 26, 2019 04:00PM Cytokinetics Announces Additional Results From FORTITUDE-ALS to be Presented at the 18th Annual NEALS Meeting
Sep 25, 2019 07:30AM Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals
Sep 16, 2019 07:33AM Cytokinetics (CYTK) Highlights Data From Phase 1 Study of CK-3773274 at HFSA 2019 Meetings
Sep 16, 2019 07:30AM Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23ʳᵈ Annual Scientific Meeting
Sep 6, 2019 04:00PM Cytokinetics Announces Presentations at the 23rd Annual HFSA Scientific Meeting
Sep 3, 2019 04:00PM Cytokinetics to Present at September Investor Conferences
Aug 8, 2019 04:06PM Cytokinetics Reports Second Quarter 2019 Financial Results
Jul 31, 2019 07:30AM Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
Jul 25, 2019 04:00PM Cytokinetics to Announce Second Quarter Results on August 8, 2019
Jul 24, 2019 07:40AM Cytokinetics (CYTK) Reports Publication of Preclinical Data Demonstrating Fast Skeletal Muscle Troponin Activator Improves Muscle Energetics
Jul 24, 2019 07:30AM Cytokinetics Announces Publication of Preclinical Data Demonstrating Fast Skeletal Muscle Troponin Activator Improves Muscle Energetics
Jul 23, 2019 07:37AM Cytokinetics (CYTK) Granted European Orphan Designation for Reldesemtiv for the Treatment of SMA
Jul 23, 2019 07:30AM Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy
Jul 22, 2019 04:00PM Cytokinetics (CYTK) Announces Preclinical Data Relating to CK-3773274 to be Presented at BCVS
Jul 22, 2019 04:00PM Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions
Jul 15, 2019 07:33AM Cytokinetics (CYTK) Reports Complete Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil
Jul 15, 2019 07:30AM Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
Jun 28, 2019 07:38AM Cytokinetics (CYTK) Announces Preclinical Data For Reldesemtiv Presented at SMA Conference
Jun 28, 2019 07:30AM Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference
Jun 24, 2019 04:00PM Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference
Jun 12, 2019 04:00PM Cytokinetics to Present at the JMP Securities Life Sciences Conference
May 30, 2019 07:30AM Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS
May 9, 2019 04:00PM Cytokinetics Reports First Quarter 2019 Financial Results
May 8, 2019 04:00PM Cytokinetics to Hold Annual Meeting of Stockholders
View More Recent Stories View Older Stories